Actively Recruiting

Phase 2
Age: 18Years +
All Genders
NCT07298941

Resilience Enhancement Following Sleep Treatment

Led by University of Virginia · Updated on 2025-12-23

300

Participants Needed

1

Research Sites

228 weeks

Total Duration

On this page

Sponsors

U

University of Virginia

Lead Sponsor

N

National Center for Complementary and Integrative Health (NCCIH)

Collaborating Sponsor

AI-Summary

What this Trial Is About

The primary objective of this study is to evaluate the efficacy of an adaptive intervention targeting both insomnia and positive affect in improving pain outcomes for adults with chronic low back pain (cLBP) and comorbid insomnia. Specifically, the study tests whether augmenting a cognitive behavioral therapy for insomnia (CBTi) program with a meditation intervention (Savoring Meditation) or a Pain Education intervention will result in greater reductions in pain intensity. Secondary objectives include evaluating improvements in insomnia severity, positive and negative affect, and overall quality of life.

CONDITIONS

Official Title

Resilience Enhancement Following Sleep Treatment

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age 18 years or older
  • Ongoing low back pain for at least 3 months with pain on at least half the days in the past 6 months
  • Average pain intensity of 4 or higher over the past 7 days on a 0-10 scale
  • Sleep-onset, maintenance, or late insomnia symptoms lasting 6 months or more causing significant distress or impairment
Not Eligible

You will not qualify if you...

  • Currently receiving behavioral treatment for insomnia
  • Currently practicing meditation regularly
  • Unstable medication use for sleep, pain, or other conditions within past 3 months
  • Irregular sleep schedules due to shift work (bedtimes outside 8:00 p.m. to 2:00 a.m. or wake times outside 4:00 a.m. to 10:00 a.m.)
  • Mental health conditions interfering with the study or untreated sleep disorders
  • No regular internet access
  • Cannot read or speak English
  • Severe cognitive impairment
  • Currently pregnant
  • Unable or unwilling to follow study protocols or deemed unsafe by the investigator

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

University of Virginia

Charlottesville, Virginia, United States, 22903

Actively Recruiting

Loading map...

Research Team

Z

Zayn Shahzad

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

SEQUENTIAL

Primary Purpose

TREATMENT

Number of Arms

3

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here